Intralesional bleomycin in palmoplantar and periungual warts: a therapeutic study

Gayatri Devi B.; P. V. Krishnam Raju; K. V. T. Gopal; Vanapalli R. Sneha

doi:10.18203/issn.2455-4529.IntJResDermatol20211387

Authors

Gayatri Devi B. Department of DVL, Maharajah's Institute of Medical Sciences, Nellimarla, Vizianagaram, Andhra Pradesh, India
P. V. Krishnam Raju Department of Dermatology, Maharajah's Institute of Medical Sciences, Nellimarla, Vizianagaram, Andhra Pradesh, India
K. V. T. Gopal Department of Dermatology, Maharajah's Institute of Medical Sciences, Nellimarla, Vizianagaram, Andhra Pradesh, India
Vanapalli R. Sneha Department of Dermatology, Maharajah's Institute of Medical Sciences, Nellimarla, Vizianagaram, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20211387

Keywords:

Bleomycin, Palmo-plantarwarts, Periungual warts

Abstract

Background: Warts are one of the most common benign growths of skin caused by human papilloma virus. No single treatment has proved to be completely effective and most therapies for palmo-plantar and periungual warts remain unsatisfactory. The present study was conducted to evaluate the therapeutic efficacy and safety of intralesional bleomycin injection in palmo-plantar and periungual warts in patients in region of south east India.

Methods: Ninety patients of multiple palmo-plantar and periungual warts were included in the study. They were infiltrated with bleomycin (1 mg/ml) till blanching. The treatment was repeated after paring of eschar at 2 weeks interval in cases with partial or no response. The patients were reviewed at monthly interval for 24 weeks to note cure, adverse effects, recurrence and outcome satisfaction levels.

Results: Out of total 305 warts, 103 (34%) were cured after 1st injection and 249 (82%) were cured after 2nd injection. The number of warts requiring more than 2 sittings was 55 (18%). At the end of study, overall cure rate was 94.5% and 10 patients showed recurrence.

Conclusions: Intralesional bleomycin injection is an effective and safe treatment option in palmo-plantar and periungual warts.

Metrics

Metrics Loading ...

References

Sterling JC .Virus infections. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s Textbook of Dermatology. 8th edition. Oxford: Wiley Blackwell. 2010;33:39-60.

Sterling JC, Gibbs S, Hussain SSH, Mustapa MFM, Handfield-Jones SE. BAD guidelines for management of cutaneous warts. Br J Dermatol. 2014;171:696-712.

Lipke MM. An armamentarium of wart treatments. Clin Med Res. 2006;4:273-93.

Bremner RM. Warts: Treatment with intralesional bleomycin. Cutis. 1976;18:264-6.

Cordero AA, Guglielmi HA. Woscoff A. The common wart. Intralesional treatment with Bleomycin sulfate. Cutis. 1980;26:319-24.

Bunney MH, Nolan MW, Buxton PK, Going SM, Prescott RJ. The Treatment of resistant warts with intralesional bleomycin: A controlled clinical trial. Br J Dermatol. 1984;110:197-207.

Soni P, Khandelwal K, Aara N, Ghiya BC, Mehta RD, Bumb RA. Efficacy of intralesional bleomycin in palmo-plantar and periungual warts. J Cutan Aesthet Surg. 2011;4:188-91.

Gibbs S, Harvey I. Topical treatments for cutaneous warts. Cochrane Library. Chichester: John Wiley and Sons. 2007;4.

Gibbs S, Harvey I, Sterling J, Sterk R. Local treatments for cutaneous warts: Systemic review. BMJ. 2002;325:461-7.

Thomas KS, Keogh-Brown MR, Chalmers JR, Fordham RJ, Holland RC, Armstrong SJ, et al . Effectiveness and cost-effectiveness of salicylic acid and cryotherapy for cutaneous warts: An economic decision model. Health Technol Assess. 2006;10:9-87.

Singh Mehta KI, Mahajan VK, Chauhan PS, Chauhan S, Sharma V, Rawat R. Evaluation of efficacy and safety of intralesional bleomycin in the treatment of common warts: Results of a pilot study. Indian J Dermatol Venereol Leprol. 2019;85:397-404.

Aziz-Jalali M, Ghafarpour G, Rezaei M, Heshmatzadeh Behzadi A, Rohani Nasab M, Nilforoushzadeh M. Efficacy of intralesional bleomycin in the treatment of resistant warts. J Skin Stem Cell. 2014;1:18875.

Shumer SM, O'Keefe EJ. Bleomycin in the treatment of recalcitrant warts. J Am Acad Dermatol. 1983;9:91-6.

Saitta P, Krishnamurthy K, Brown LH. Bleomycin in dermatology: A review of intralesional applications. Dermatol Surg. 2008;34:1299-313.

Hayes ME, O'Keefe EJ. Reduced dose of bleomycin in the treatment of recalcitrant warts. J Am Acad Dermatol. 1986;15:1002-6.

Lewis TG, Nydorf ED. Intralesional bleomycin for warts: A review. J Drugs Dermatol. 2006;5:499-504.

Sterling JC, Handfield-Jones S, Hudson PM; British Association of Dermatologists. Guidelines for the management of cutaneous warts. Br J Dermatol. 2001;144:4-11.

Munn SE, Higgins E, Marshall M, Clement M. A new method of intralesional bleomycin therapy in the treatment of recalcitrant warts. Br J Dermatol. 1996;135:969-71.

Shelley WB, Shelley ED. Intralesional bleomycin sulfate therapy for warts. A novel bifurcated needle puncture technique. Arch Dermatol. 1991;127:234-6.

Dhar SB, Rashid MM, Islam A, Bhuiyan M. Intralesional bleomycin in the treatment of cutaneous warts: A randomized clinical trial comparing it with cryotherapy. Indian J Dermatol Venereol Leprol. 2009;75:262-7.

Agius E, Mooney JM, Bezzina AC, Yu RC. Dermojet delivery of bleomycin for the treatment of recalcitrant plantar warts. J Dermatol Treat. 2006;17:112-6.

Adalatkhah H, Khalilollahi H, Amini N, Sadeghi-Bazargani H. Compared therapeutic efficacy between intralesional bleomycin and cryotherapy for common warts: a randomized clinical trial. Dermatol Online J. 2007;13(3):4.

Unni M, Tapare V. Intralesional bleomycin in the treatment of common warts. Indian J Drugs Dermatol. 2017;3:73-6.